Works by Henderson, Melissa A.


Results: 13
    1

    Generating CAR T cells from tumor-infiltrating lymphocytes.

    Published in:
    Therapeutic Advances in Vaccines & Immunotherapy, 2021, v. 9, n. 50, p. 1, doi. 10.1177/25151355211017119
    By:
    • Mills, Jane K.;
    • Henderson, Melissa A.;
    • Giuffrida, Lauren;
    • Petrone, Pasquale;
    • Westwood, Jennifer A.;
    • Darcy, Phillip K.;
    • Neeson, Paul J.;
    • Kershaw, Michael H.;
    • Gyorki, David E.
    Publication type:
    Article
    2

    Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancer.

    Published in:
    Nature Communications, 2017, v. 8, n. 1, p. 1, doi. 10.1038/s41467-017-00728-9
    By:
    • Dushyanthen, Sathana;
    • Zhi Ling Teo;
    • Caramia, Franco;
    • Savas, Peter;
    • Mintoff, Christopher P.;
    • Virassamy, Balaji;
    • Henderson, Melissa A.;
    • Luen, Stephen J.;
    • Mansour, Mariam;
    • Kershaw, Michael H.;
    • Trapani, Joseph A.;
    • Neeson, Paul J.;
    • Salgado, Roberto;
    • McArthur, Grant A.;
    • Balko, Justin M.;
    • Beavis, Paul A.;
    • Darcy, Phillip K.;
    • Loi, Sherene
    Publication type:
    Article
    3

    PTPN2 phosphatase deletion in T cells promotes anti‐tumour immunity and CAR T‐cell efficacy in solid tumours.

    Published in:
    EMBO Journal, 2020, v. 39, n. 2, p. N.PAG, doi. 10.15252/embj.2019103637
    By:
    • Wiede, Florian;
    • Lu, Kun‐Hui;
    • Du, Xin;
    • Liang, Shuwei;
    • Hochheiser, Katharina;
    • Dodd, Garron T;
    • Goh, Pei K;
    • Kearney, Conor;
    • Meyran, Deborah;
    • Beavis, Paul A;
    • Henderson, Melissa A;
    • Park, Simone L;
    • Waithman, Jason;
    • Zhang, Sheng;
    • Zhang, Zhong‐Yin;
    • Oliaro, Jane;
    • Gebhardt, Thomas;
    • Darcy, Phillip K;
    • Tiganis, Tony
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11

    MAIT cells regulate NK cell-mediated tumor immunity.

    Published in:
    Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-25009-4
    By:
    • Petley, Emma V.;
    • Koay, Hui-Fern;
    • Henderson, Melissa A.;
    • Sek, Kevin;
    • Todd, Kirsten L.;
    • Keam, Simon P.;
    • Lai, Junyun;
    • House, Imran G.;
    • Li, Jasmine;
    • Zethoven, Magnus;
    • Chen, Amanda X. Y.;
    • Oliver, Amanda J.;
    • Michie, Jessica;
    • Freeman, Andrew J.;
    • Giuffrida, Lauren;
    • Chan, Jack D.;
    • Pizzolla, Angela;
    • Mak, Jeffrey Y. W.;
    • McCulloch, Timothy R.;
    • Souza-Fonseca-Guimaraes, Fernando
    Publication type:
    Article
    12

    CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy.

    Published in:
    Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-23331-5
    By:
    • Giuffrida, Lauren;
    • Sek, Kevin;
    • Henderson, Melissa A.;
    • Lai, Junyun;
    • Chen, Amanda X. Y.;
    • Meyran, Deborah;
    • Todd, Kirsten L.;
    • Petley, Emma V.;
    • Mardiana, Sherly;
    • Mølck, Christina;
    • Stewart, Gregory D.;
    • Solomon, Benjamin J.;
    • Parish, Ian A.;
    • Neeson, Paul J.;
    • Harrison, Simon J.;
    • Kats, Lev M.;
    • House, Imran G.;
    • Darcy, Phillip K.;
    • Beavis, Paul A.
    Publication type:
    Article
    13